Open Access
LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance
Moriya Shmerling, Michael Chalik, Nechama I. Smorodinsky, Alan Meeker, Sujayita Roy, Orit Sagi-Assif, Tsipi Meshel, Artem Danilevsky, Noam Shomron, Shmuel Levinger, Bar Nishry, David Baruchi, Avital Shargorodsky, Ravit Ziv, Avital Sarusi-Portuguez, Maoz Lahav, Marcelo Ehrlich, Bryony Braschi, Elspeth Bruford, Isaac P. Witz and Daniel H. Wreschner
ImmunoHorizons April 1, 2022, 6 (4) 253-272; DOI: https://doi.org/10.4049/immunohorizons.2200018
Moriya Shmerling
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Michael Chalik
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Nechama I. Smorodinsky
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Alan Meeker
†The Johns Hopkins University School of Medicine, Baltimore, MD;
Sujayita Roy
†The Johns Hopkins University School of Medicine, Baltimore, MD;
Orit Sagi-Assif
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Tsipi Meshel
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Artem Danilevsky
‡Faculty of Medicine and Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Ramat Aviv, Israel;
Noam Shomron
‡Faculty of Medicine and Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Ramat Aviv, Israel;
Shmuel Levinger
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Bar Nishry
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
David Baruchi
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Avital Shargorodsky
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Ravit Ziv
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Avital Sarusi-Portuguez
§Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel;
Maoz Lahav
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Marcelo Ehrlich
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Bryony Braschi
¶HUGO Gene Nomenclature Committee, European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom; and
Elspeth Bruford
¶HUGO Gene Nomenclature Committee, European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom; and
‖Department of Haematology, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom
Isaac P. Witz
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;
Daniel H. Wreschner
*Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Israel;